北京招聘

北京爱思益普生物科技股份有限公司2010年成立，公司专注于基于靶点的新药筛选服务，以及中枢神经系统和心血管系统新药研发服务，公司的技术特色是离子通道靶点的新药发现和安全性评价服务。公司建立了80多个离子通道细胞系文库，50多个G蛋白偶联受体细胞系，300多个酶和激酶靶点以及40多个核受体的专业性药物靶点筛选服务和脱靶效应筛选及早期成药性评价平台，并建立了专业的中枢神经系统和心血管系统新药研发服务平台。公司创始人为国外具有多年工作经历的专家团队，致力于以高效、专业的服务，帮助新药研发企业快速有效地推进新药研发项目。
ICE Bioscience established in 2010, an Advent portfolio company is a leading life sciences research and development organization that provides biopharmaceutical clients and partners with widespread and specific drug discovery and development services. ICE Bioscience is specialized in delivering pre-clinical research solutions in the field of cell line development, protein extension and target-based drug screening on various druggable targets with a particular emphasis on the central nervous and cardiovascular systems. The company also focusses on QT prolongation related cardiac safety evaluation services.
The company has established adaptable drug screening platform for more than 80 Ion channels, 80 GPCRs , 400 kinase targets and 40 nuclear receptors. We provide professional drug target screening and off target panel for early stage safety evaluation. The company has established full ex vivo cardiac safety assessment panel for pro Arrhythmia .The company has also established numerous disease related animal model of Central Nervous (Pain/ Neurodegeneration disease (AD/PD)/ Epilepsy models) and Cardiovascular system (arrhythmia, myocardial ischemia, heart failure) in order to provide specific drug targets for new drug research and development (R&D) services.
The founders of the company have distinguished expertise with many years of international work experience and exposure. They and their team is committed in providing efficient and professional services to help new drug research and development to promote new drug R&D projects quickly and effectively.